Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Microbiologyopen ; 8(12): e921, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31441241

RESUMEN

Rhodobacter capsulatus fixes atmospheric nitrogen (N2 ) by a molybdenum (Mo)-nitrogenase and a Mo-free iron (Fe)-nitrogenase, whose production is induced or repressed by Mo, respectively. At low nanomolar Mo concentrations, both isoenzymes are synthesized and contribute to nitrogen fixation. Here we examined the regulatory interplay of the central transcriptional activators NifA and AnfA by proteome profiling. As expected from earlier studies, synthesis of the structural proteins of Mo-nitrogenase (NifHDK) and Fe-nitrogenase (AnfHDGK) required NifA and AnfA, respectively, both of which depend on the alternative sigma factor RpoN to activate expression of their target genes. Unexpectedly, NifA was found to be essential for the synthesis of Fe-nitrogenase, electron supply to both nitrogenases, biosynthesis of their cofactors, and production of RpoN. Apparently, RpoN is the only NifA-dependent factor required for target gene activation by AnfA, since plasmid-borne rpoN restored anfH transcription in a NifA-deficient strain. However, plasmid-borne rpoN did not restore Fe-nitrogenase activity in this strain. Taken together, NifA requirement for synthesis and activity of both nitrogenases suggests that Fe-nitrogenase functions as a complementary nitrogenase rather than an alternative isoenzyme in R. capsulatus.


Asunto(s)
Proteínas Bacterianas/metabolismo , Regulación Bacteriana de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Rhodobacter capsulatus/genética , Rhodobacter capsulatus/metabolismo , Factores de Transcripción/metabolismo , Proteínas Bacterianas/genética , Sitios de Unión , Genes Bacterianos , Genes Reporteros , Familia de Multigenes , Nitrógeno/metabolismo , Fijación del Nitrógeno/genética , Unión Proteica , Proteoma , Proteómica/métodos , Factores de Transcripción/genética
2.
Biochim Biophys Acta Biomembr ; 1860(5): 1114-1124, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29317198

RESUMEN

Particularly in Asia medicinal plants with antimicrobial activity are used for therapeutic purpose. One such plant-derived antibiotic is rhodomyrtone (Rom) isolated from Rhodomyrtus tomentosa leaves. Rom shows high antibacterial activity against a wide range of Gram-positive bacteria, however, its mode of action is still unclear. Reporter gene assays and proteomic profiling experiments in Bacillus subtilis indicate that Rom does not address classical antibiotic targets like translation, transcription or DNA replication, but acts at the cytoplasmic membrane. In Staphylococcus aureus, Rom decreases the membrane potential within seconds and at low doses, causes release of ATP and even the excretion of cytoplasmic proteins (ECP), but does not induce pore-formation as for example nisin. Lipid staining revealed that Rom induces local membrane damage. Rom's antimicrobial activity can be antagonized in the presence of a very narrow spectrum of saturated fatty acids (C15:0, C16:0, or C18:0) that most likely contribute to counteract the membrane damage. Gram-negative bacteria are resistant to Rom, presumably due to reduced penetration through the outer membrane and its neutralization by LPS. Rom is cytotoxic for many eukaryotic cells and studies with human erythrocytes showed that Rom induces eryptosis accompanied by erythrocyte shrinkage, cell membrane blebbing, and membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Rom's distinctive interaction with the cytoplasmic membrane reminds on the amphipathic, alpha-helical peptides, the phenol-soluble modulins (PSMs), and renders Rom an important tool for the investigation of membrane physiology.


Asunto(s)
Antiinfecciosos/farmacología , Membranas/efectos de los fármacos , Xantonas/farmacología , Animales , Células 3T3 BALB , Bacillus subtilis , Células Cultivadas , Células HeLa , Hemólisis/efectos de los fármacos , Humanos , Potenciales de la Membrana/efectos de los fármacos , Membranas/fisiología , Ratones , Pruebas de Sensibilidad Microbiana , Staphylococcus aureus
3.
Proteomics Clin Appl ; 10(9-10): 1036-1048, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27329548

RESUMEN

PURPOSE: Trimethoprim is a folate biosynthesis inhibitor. Tetrahydrofolates are essential for the transfer of C1 units in several biochemical pathways including purine, thymine, methionine, and glycine biosynthesis. This study addressed the effects of folate biosynthesis inhibition on bacterial physiology. EXPERIMENTAL DESIGN: Two complementary proteomic approaches were employed to analyze the response of Bacillus subtilis to trimethoprim. Acute changes in protein synthesis rates were monitored by radioactive pulse labeling of newly synthesized proteins and subsequent 2DE analysis. Changes in protein levels were detected using gel-free quantitative MS. RESULTS: Proteins involved in purine and histidine biosynthesis, the σB -dependent general stress response, and sporulation were upregulated. Most prominently, the PurR-regulon required for de novo purine biosynthesis was derepressed indicating purine depletion. The general stress response was activated energy dependently and in a subpopulation of treated cultures an early onset of sporulation was observed, most likely triggered by low guanosine triphosphate levels. Supplementation of adenosine triphosphate, adenosine, and guanosine to the medium substantially decreased antibacterial activity, showing that purine depletion becomes the bottleneck in trimethoprim-treated B. subtilis. CONCLUSIONS AND CLINICAL RELEVANCE: The frequently prescribed antibiotic trimethoprim causes purine depletion in B. subtilis, which can be complemented by supplementing purines to the medium.


Asunto(s)
Antibacterianos/farmacología , Bacillus subtilis/efectos de los fármacos , Bacillus subtilis/metabolismo , Purinas/biosíntesis , Trimetoprim/farmacología , Adenosina/farmacología , Adenosina Trifosfato/farmacología , Bacillus subtilis/fisiología , Proteínas Bacterianas/metabolismo , Metabolismo Energético/efectos de los fármacos , Guanosina/farmacología , Proteómica , Esporas Bacterianas/efectos de los fármacos , Esporas Bacterianas/fisiología , Estrés Fisiológico/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA